Voet P - Search Results

1

Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12.

Van Hoecke C, Fu D, De Grave D, Voet P, Lebacq E. Van Hoecke C, et al. Among authors: voet p. Vaccine. 1998 Oct;16(17):1688-92. doi: 10.1016/s0264-410x(98)00052-8. Vaccine. 1998. PMID: 9713948

2

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults.

Van Hoecke C, Comberbach M, De Grave D, Desmons P, Fu D, Hauser P, Lebacq E, Lobet Y, Voet P. Van Hoecke C, et al. Among authors: voet p. Vaccine. 1996 Dec;14(17-18):1620-6. doi: 10.1016/s0264-410x(96)00146-6. Vaccine. 1996. PMID: 9032890 Clinical Trial.

3

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

Leroux-Roels G, Van Hecke E, Michielsen W, Voet P, Hauser P, Pêtre J. Leroux-Roels G, et al. Among authors: voet p. Vaccine. 1994 Jul;12(9):812-8. doi: 10.1016/0264-410x(94)90290-9. Vaccine. 1994. PMID: 7975860 Clinical Trial.

4

Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.

Kurtenbach K, Dizij A, Voet P, Hauser P, Simon MM. Kurtenbach K, et al. Among authors: voet p. Vaccine. 1997 Oct;15(15):1670-4. doi: 10.1016/s0264-410x(97)00086-8. Vaccine. 1997. PMID: 9364698

5

Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.

Pettersson A, Kortekaas J, Weynants VE, Voet P, Poolman JT, Bos MP, Tommassen J. Pettersson A, et al. Among authors: voet p. Vaccine. 2006 Apr 24;24(17):3545-57. doi: 10.1016/j.vaccine.2006.02.003. Epub 2006 Feb 20. Vaccine. 2006. PMID: 16517031

6

Immunological properties of recombinant HBsAg produced in yeast.

Hauser P, Voet P, Simoen E, Thomas HC, Pêtre J, De Wilde M, Stephenne J. Hauser P, et al. Among authors: voet p. Postgrad Med J. 1987;63 Suppl 2:83-91. Postgrad Med J. 1987. PMID: 2446304

7

Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.

Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E. Pal U, et al. Among authors: voet p. J Immunol. 2001 Jun 15;166(12):7398-403. doi: 10.4049/jimmunol.166.12.7398. J Immunol. 2001. PMID: 11390491

8

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.

Gern L, Hu CM, Voet P, Hauser P, Lobet Y. Gern L, et al. Among authors: voet p. Vaccine. 1997 Oct;15(14):1551-7. doi: 10.1016/s0264-410x(97)00066-2. Vaccine. 1997. PMID: 9330467

9

Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.

Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, Capiau C, Desmons P, Voet P, Dearwester D, Frantz JC. Golde WT, et al. Among authors: voet p. Infect Immun. 1997 Mar;65(3):882-9. doi: 10.1128/IAI.65.3.882-889.1997. Infect Immun. 1997. PMID: 9038292 Free PMC article.

10

Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Liang FT, Aberer E, Cinco M, Gern L, Hu CM, Lobet YN, Ruscio M, Voet PE Jr, Weynants VE, Philipp MT. Liang FT, et al. Among authors: voet pe jr. J Infect Dis. 2000 Nov;182(5):1455-62. doi: 10.1086/315862. Epub 2000 Oct 9. J Infect Dis. 2000. PMID: 11023468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters